Skip to main content
BAXTER INTERNATIONAL INC logo

BAXTER INTERNATIONAL INC — Investor Relations & Filings

Ticker · BAX ISIN · US0718131099 LEI · J5OIVXX3P24RJRW5CK77 US Manufacturing
Open in API
Filings indexed 2,456 across all filing types
Latest filing 2021-05-06 Director's Dealing
Country US United States of America
Listing US BAX

About BAXTER INTERNATIONAL INC

https://www.baxter.com/

Baxter International Inc. is a global healthcare company focused on saving and sustaining lives. The company provides a broad portfolio of essential products across renal care, hospital, and surgical settings. Key offerings include technologies for acute and chronic dialysis, sterile intravenous (IV) solutions, infusion systems, clinical nutrition, and critical care. Baxter develops, manufactures, and markets a range of medical devices, connected care solutions, and advanced injectable pharmaceuticals. The company's products are used by healthcare professionals in hospitals, clinics, and homes to provide smarter, more personalized care for patients.

Recent filings

Filing Released Lang Actions
PRIMARY DOCUMENT
Director's Dealing
2021-05-06 English
PRIMARY DOCUMENT
Director's Dealing
2021-05-06 English
8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated May 4, 2021, by Baxter International Inc. The key content is the submission of matters to a vote of security holders at the company's annual meeting, including election results of directors, approval of compensation, appointment of auditors, and approval of various plans and proposals. This type of filing corresponds to the official results from shareholder votes at a general meeting. The document is not a full annual report, earnings release, or management discussion, but specifically reports voting outcomes. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is sufficient and contains detailed vote counts, confirming it is not merely an announcement of a report but the actual voting results.
2021-05-05 English
S-8
Share Issue/Capital Change Classification · 100% confidence The document is a Form S-8 Registration Statement filed with the SEC by Baxter International Inc. It registers additional shares under an Employee Stock Purchase Plan. The text includes details about the registration fee, incorporation by reference of prior filings (10-K, 10-Q, 8-K), and legal indemnification provisions. Form S-8 is a registration statement for securities to be offered to employees and is not a financial report, earnings release, or management discussion. It is a capital market filing related to securities registration and issuance. Therefore, the most appropriate classification is 'Share Issue/Capital Change' (SHA). The document length and content confirm it is the registration statement itself, not just an announcement or certification.
2021-05-04 English
S-8
Regulatory Filings Classification · 95% confidence The document is a Form S-8 Registration Statement filed with the SEC, which is used to register securities to be offered under employee benefit plans such as incentive plans. It includes details about the securities to be registered, the plan under which they will be issued, indemnification provisions, and incorporation by reference of other filings. It is not a financial report, earnings release, or management discussion, but a regulatory filing related to securities registration. The document is lengthy (15,000 characters) and contains detailed legal and regulatory information specific to the registration of shares under an incentive plan. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2021-05-04 English
S-8 POS
Regulatory Filings Classification · 100% confidence The document is a Post-Effective Amendment No. 1 to a Form S-8 Registration Statement filed with the SEC by Baxter International Inc. It relates to the registration of securities under the Securities Act of 1933, specifically concerning the Baxter International Inc. 2021 Incentive Plan and the prior 2015 Incentive Plan. The document includes legal and regulatory disclosures, indemnification provisions, incorporation by reference of other SEC filings, and exhibits related to the registration statement. It is not a financial report, earnings release, or management discussion, but rather a regulatory filing related to securities registration and employee benefit plans. The document is lengthy (15,000 characters) and contains detailed regulatory and legal information typical of SEC registration statements and amendments. Therefore, the appropriate classification is Regulatory Filings (RNS).
2021-05-04 English

Browse filings by year

33 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.